Abstract 2805: Exome sequencing identifies frequent mutation of the SWI/SNF complex gene <i>PBRM1</i> in renal carcinoma

Ignacio Varela(Wellcome Sanger Institute), Patrick Tarpey(Wellcome Sanger Institute), Keiran Raine(Wellcome Sanger Institute), Dachuan Huang(National Cancer Centre Singapore), Choon Kiat Ong(National Cancer Centre Singapore), Philip Stephens(Wellcome Sanger Institute), Helen Davies(Wellcome Sanger Institute), David Jones(Wellcome Sanger Institute), Meng‐Lay Lin(Wellcome Sanger Institute), Jon W. Teague(Wellcome Sanger Institute), Graham R. Bignell(Wellcome Sanger Institute), Adam P. Butler(Wellcome Sanger Institute), Juok Cho(Wellcome Sanger Institute), Gillian L. Dalgliesh(Wellcome Sanger Institute), Danushka Galappaththige(Wellcome Sanger Institute), Chris Greenman(Wellcome Sanger Institute), Claire Hardy(Wellcome Sanger Institute), Mingming Jia(Wellcome Sanger Institute), Calli Latimer(Wellcome Sanger Institute), King Wai Lau(Wellcome Sanger Institute), John L. Marshall(Wellcome Sanger Institute), Stuart McLaren(Wellcome Sanger Institute), Andrew Menzies(Wellcome Sanger Institute), Laura Mudie(Wellcome Sanger Institute), Lucy Stebbings(Wellcome Sanger Institute), David A. Largaespada(University of Minnesota), Lodewyk F.A. Wessels(Inserm), Stéphane Richard(Institut Gustave Roussy), Richard J. Kahnoski(Spectrum Health), John Anema(Spectrum Health), David A. Tuveson(Cancer Research UK), Pedro A. Pérez–Mancera(Cancer Research UK), Ville Mustonen(Cancer Research UK), Andrej Fischer(Wellcome Sanger Institute), David J. Adams(Wellcome Sanger Institute), Alistair G. Rust(Wellcome Sanger Institute), Waraporn Chan-on(National Cancer Centre Singapore), Chutima Subimerb(National Cancer Centre Singapore), Karl Dykema(Van Andel Institute), Kyle A. Furge(Van Andel Institute), Peter J. Campbell(Wellcome Sanger Institute), Bin Tean Teh(Van Andel Institute), Michael R. Stratton(Wellcome Sanger Institute), P. Andrew Futreal(Wellcome Sanger Institute)
Cancer Research
April 1, 2011
Cited by 1

Abstract

Abstract The genetics of renal cancer is dominated by inactivation of the VHL tumour suppressor gene in clear cell carcinoma (ccRCC), the commonest histological subtype. A recent large-scale screen of ∼3500 genes by PCR-based exon re-sequencing identified several new cancer genes in ccRCC including UTX (KDM6A), JARID1C (KDM5C) and SETD2. These genes encode enzymes that demethylate (UTX, JARID1C) or methylate (SETD2) key lysine residues of histone H3. Modification of the methylation state of these lysine residues of histone H3 regulates chromatin structure and is implicated in transcriptional control. However, together these mutations are present in fewer than 15% of ccRCC, suggesting the existence of additional, currently unidentified cancer genes. Here, we have sequenced the protein coding exome in a series of primary ccRCC and report the identification of the SWI/SNF chromatin remodeling complex gene PBRM1 as a second major ccRCC cancer gene, with truncating mutations in 41% (92/227) of cases. These data further elucidate the somatic genetic architecture of ccRCC and emphasize the marked contribution of aberrant chromatin biology. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2805. doi:10.1158/1538-7445.AM2011-2805


Related Papers

No related papers found

Powered by citation graph analysis